MetLife, Inc. (NYSE:MET) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 12.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,113,108 shares of the financial services provider's stock after purchasing an additional 564,383 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.74% of MetLife worth $418,661,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Price T Rowe Associates Inc. MD raised its position in shares of MetLife by 33.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 24,663,239 shares of the financial services provider's stock worth $2,019,427,000 after purchasing an additional 6,213,923 shares during the period. Geode Capital Management LLC raised its position in shares of MetLife by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 11,931,536 shares of the financial services provider's stock worth $973,901,000 after purchasing an additional 158,107 shares during the period. Norges Bank acquired a new stake in shares of MetLife during the fourth quarter worth $730,716,000. Bank of New York Mellon Corp raised its position in shares of MetLife by 109.2% during the fourth quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock worth $722,727,000 after purchasing an additional 4,606,748 shares during the period. Finally, Northern Trust Corp raised its position in shares of MetLife by 15.7% during the fourth quarter. Northern Trust Corp now owns 7,052,202 shares of the financial services provider's stock worth $577,434,000 after purchasing an additional 958,458 shares during the period. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Price Performance

MetLife stock opened at $80.25 on Wednesday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market capitalization of $53.87 billion, a PE ratio of 13.44, a price-to-earnings-growth ratio of 0.65 and a beta of 0.85. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The business has a 50 day simple moving average of $77.12 and a 200 day simple moving average of $81.15.

MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share for the quarter, missing analysts' consensus estimates of $2.00 by ($0.04). MetLife had a net margin of 6.19% and a return on equity of 20.42%. The business had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. During the same period in the prior year, the business earned $1.83 earnings per share. The company's revenue for the quarter was up 15.6% on a year-over-year basis. On average, sell-side analysts forecast that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife announced that its board has approved a stock buyback plan on Wednesday, April 30th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board believes its shares are undervalued.

MetLife Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 10th. Stockholders of record on Tuesday, May 6th will be paid a $0.5675 dividend. This is a boost from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 annualized dividend and a dividend yield of 2.83%. The ex-dividend date is Tuesday, May 6th. MetLife's dividend payout ratio (DPR) is 36.91%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on MET. UBS Group upped their price target on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research report on Wednesday, April 2nd. BMO Capital Markets began coverage on MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price target on the stock. JPMorgan Chase & Co. dropped their price target on MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods dropped their price target on MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, Wells Fargo & Company upped their price target on MetLife from $91.00 to $94.00 and gave the company an "overweight" rating in a research report on Tuesday, May 6th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $93.08.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.